日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An attenuated coxsackievirus B5 mutant carrying VP1-N157K retains oncolytic potency against non-small cell lung cancer

携带VP1-N157K突变的减毒柯萨奇病毒B5突变体仍保留对非小细胞肺癌的溶瘤活性

Song, Lifang; Cui, Bopei; Gao, Qiushuang; Hu, Chaoying; Wang, Qian; Zhang, Jialu; Li, Yajing; Liu, Guanxing; Fu, Yulong; Wang, Ying; Li, Kelei; Hao, Xiaotian; Gao, Fan; Wu, Xing; Mao, Qunying; Liang, Zhenglun; Yu, Yongxin

Anti-tumor analysis of the RIG-I agonist in vitro and in vivo.

RIG-I激动剂的体外和体内抗肿瘤分析。

Wang Qian, Song Ziyang, Cui Bopei, An Chaoqiang, Gao Fan, Liu Mingchen, Li Lu, Ma Xiao, Wu Xing, Liang Zhenglun

Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard

中国抗SARS-CoV-2中和抗体国家标准的建立:首个可追溯至世卫组织国际标准的国家标准

Guan, Lidong; Mao, Qunying; Tan, Dejiang; Liu, Jianyang; Zhang, Xuanxuan; Li, Lu; Liu, Mingchen; Wang, Zhongfang; Cheng, Feiran; Cui, Bopei; He, Qian; Wang, Qingzhou; Gao, Fan; Wang, Yiping; Bian, Lianlian; Wu, Xing; Hou, Jifeng; Liang, Zhenglun; Xu, Miao

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques

利用腺病毒载体和灭活疫苗进行异源免疫,可有效保护小鼠和猕猴免受SARS-CoV-2变种病毒的感染。

He, Qian; Mao, Qunying; Zhang, Jialu; Gao, Fan; Bai, Yu; Cui, Bopei; Liu, Jianyang; An, Chaoqiang; Wang, Qian; Yan, Xujia; Yang, Jinghuan; Song, Lifang; Song, Ziyang; Liu, Dong; Yuan, Yadi; Sun, Jing; Zhao, Jincun; Bian, Lianlian; Wu, Xing; Huang, Weijin; Li, Changgui; Wang, Junzhi; Liang, Zhenglun; Xu, Miao

COVID-19 vaccines: progress and understanding on quality control and evaluation

新冠疫苗:质量控制和评估方面的进展与认识

Mao, Qunying; Xu, Miao; He, Qian; Li, Changgui; Meng, Shufang; Wang, Yiping; Cui, Bopei; Liang, Zhenglun; Wang, Junzhi

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy

EV71亚基因型之间的交叉抗原性:对疫苗效力的影响

Liu, Pei; Yuan, Yadi; Cui, Bopei; Huo, Yaqian; Bian, Lianlian; Chen, Lei; Liu, Siyuan; Wang, Chenfei; Xu, Yingzhi; Tedcastle, Alison; Gao, Fan; Mao, Qunying; Martin, Javier; Liang, Zhenglun

A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine

疫苗中柯萨奇病毒A16抗原的统一定量酶联免疫吸附试验

Cui, Bopei; Cai, Fang; Gao, Fan; Bian, Lianlian; Wu, Ruixia; Du, Ruixiao; Wu, Xing; Liu, Pei; Song, Lifang; Cui, Lisha; Yuan, Yadi; Liu, Siyuan; Ye, Xiangzhong; Cheng, Tong; Mao, Qunying; Gao, Qiang; Liang, Zhenglun

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains

柯萨奇病毒A10疫苗株交叉中和活性的评价

Huo, Yaqian; Yang, Jinghuan; Liu, Pei; Cui, Bopei; Wang, Chenfei; Liu, Siyuan; Dong, Fangyu; Yan, Xujia; Bian, Lianlian; Gao, Fan; Wu, Xing; Zhou, Jiuyue; Cheng, Tong; Li, Xiuling; Mao, Qunying; Liang, Zhenglun

Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10

开发一种基于假病毒的检测方法,用于测量针对柯萨奇病毒A10的中和抗体

Li, Kelei; Dong, Fangyu; Cui, Bopei; Cui, Lisha; Liu, Pei; Ma, Chao; Zheng, Haifa; Wu, Xing; Liang, Zhenglun

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge

一种潜在的治疗性中和单克隆抗体,特异性针对多种柯萨奇病毒A16毒株的攻击

Du, Ruixiao; Mao, Qunying; Hu, Yalin; Lang, Shuhui; Sun, Shiyang; Li, Kelei; Gao, Fan; Bian, Lianlian; Yang, Ce; Cui, Bopei; Xu, Longfa; Cheng, Tong; Liang, Zhenglun